E Claassen

Towards improved process efficiency in vaccine innovation: The Vaccine Innovation Cycle as a validated, conceptual stage-gate model.

L H M Van de Burgwal, C Dos S Ribeiro, M B Van der Waal, 2018, Vaccine.

Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a primary systemic in vivo immune response.

E Claassen, P. Linsley, F. Finkelman, 1995, Journal of immunology.

Immunological functions and in vivo cell-cell interactions of T cells in the spleen.

E Claassen, E. Claassen, A. V. D. van den Eertwegh, 1992, Critical reviews in immunology.

Detection of human cytokines in situ using antibody and probe based methods.

E Claassen, E. Claassen, W. Boersma, 1995, Journal of immunological methods.

A novel carbodiimide coupling method for synthetic peptides. Enhanced anti-peptide antibody responses.

E Claassen, E. Claassen, W. Boersma, 1990, Journal of immunological methods.